Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$27,000.00

Investigating Protein Turnover in Hyperactivated Signaling Pathways: Implications for Cancer Precision Medicine

EF 2024-25

Résumé
Protein homeostasis is a process in cells that regulates the synthesis, folding, and degradation of proteins. Cells rely on a large network of proteins to maintain protein homeostasis, with chaperone proteins constituting a significant portion of this network. Chaperones fold newly synthesized proteins into their functional three-dimensional structures and maintain this folding throughout the protein lifetime. Chaperones play a significant role in cancer cells, where the mutations found in cancer-causing proteins can make proper folding difficult. One chaperone notably implicated in cancer is heat shock protein 90 (Hsp90). Hsp90 folds a wide array of proteins, with two examples being the c-src and v-src proteins. Although they are very similar, their dependence on Hsp90 varies significantly. When Hsp90 is inhibited, the highly active v-src is almost immediately degraded, whereas the less active c-src is only moderately affected. This observation of a highly active protein having an increased reliance on chaperones informs our hypothesis: highly active proteins are degraded faster than less active proteins. To test this, we will increase the activity of different proteins in a pulse-chase experiment and measure the degradation rate of these proteins with mass spectrometry. If our hypothesis is supported, this method could be applied in precision medicine for cancer treatment. Hyperactivation of signaling pathways has been reported in multiple cancers, and these hyperactivated pathways can drive tumor formation. Using this method, we can determine which signaling pathways in a patient's tumor are degrading faster and therefore could be driving tumor formation. Then, an appropriate drug that targets that exact pathway can be quickly administered to the patient.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529750
Name
Mevel Alexa
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating Protein Turnover in Hyperactivated Signaling Pathways: Implications for Cancer Precision Medicine
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Hyperactivation; Mass Spectrometry; Molecular Chaperones; Precision Medicine; Protein Turnover; Proteostasis; Pulse-Chase
Abstract
Protein homeostasis is a process in cells that regulates the synthesis, folding, and degradation of proteins. Cells rely on a large network of proteins to maintain protein homeostasis, with chaperone proteins constituting a significant portion of this network. Chaperones fold newly synthesized proteins into their functional three-dimensional structures and maintain this folding throughout the protein lifetime. Chaperones play a significant role in cancer cells, where the mutations found in cancer-causing proteins can make proper folding difficult. One chaperone notably implicated in cancer is heat shock protein 90 (Hsp90). Hsp90 folds a wide array of proteins, with two examples being the c-src and v-src proteins. Although they are very similar, their dependence on Hsp90 varies significantly. When Hsp90 is inhibited, the highly active v-src is almost immediately degraded, whereas the less active c-src is only moderately affected. This observation of a highly active protein having an increased reliance on chaperones informs our hypothesis: highly active proteins are degraded faster than less active proteins. To test this, we will increase the activity of different proteins in a pulse-chase experiment and measure the degradation rate of these proteins with mass spectrometry. If our hypothesis is supported, this method could be applied in precision medicine for cancer treatment. Hyperactivation of signaling pathways has been reported in multiple cancers, and these hyperactivated pathways can drive tumor formation. Using this method, we can determine which signaling pathways in a patient's tumor are degrading faster and therefore could be driving tumor formation. Then, an appropriate drug that targets that exact pathway can be quickly administered to the patient.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mevel, Alexa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~